[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-DRUG":3,"homepage-market-summary":30,"stock-news-DRUG":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":14},"DRUG","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":9,"founded":9,"is_fund":13,"issuer":9,"category":9},"Bright Minds Biosciences Inc. Common Stock","Nasdaq",null,"Common Stock","Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.","25",false,{"close":15,"open":16,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},50.69,49.61,51.04,48.75,49.21,1.48,3.01,154685.293715,3017,49.8737,123.75,48.53,198255.808393828,2.9,1390,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":154},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":13,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":13},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":39},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":39},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},20,[175,181,187,193,199,205,211,217,223,229,234,239,244,249,254,259,263,268,272,276],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"The Best Healthcare Stocks to Buy - morningstar.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTE53Ulc0MVRkanRrTk40aHM3OVZvMGVnbjZsNlBIdldiTGhNSW50Q2Vkel9nbVlTWks5SWVvSUMxTVM5YTR5a0FuMDV5WEhQSnRUUG1pTTZYbmJUcWhaSS1yaFZMZG5kZmxBaU5oUkZn?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","The Best Healthcare Stocks to Buy morningstar.com","morningstar.com",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals - CNBC","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxQc2hUNHk3WDNZWVBBTExZdHZHWU95QTV2dEVOQVd6bFMwNXN4Z2tlanlrYmxuc3NRaEJPbFJLcHh4QlNycWRSNnlTb2dwb2E4M0x2b3lqbElqVXdsWFFDaDNvbFVOaVdVbGFEeW9QRm9nSXlmaEJ4ZXR6Q3JNVWRCeWdWaDBabWVwVFJxX3dIblpQY3I1NjZkNnVHbGV6NUtGQmh2SW5xQ2FjVFQ2WUVXTklB0gG3AUFVX3lxTE9HdHptLWtVY0V6NXEwVWgwbVl6SWdsWC13VXZkaWlyclVyTlpkUGIxdHpGZXhvQk5yazcxajRnZk5WZHRseHdMRmp6R3REWDczbi1kaXR2cjdsSUJCMkRhVjlweXpmSWlFS19iLWpfemNQNy1kRW9VMkJjbVIzeFE2MnMzV3lLOFk5SjZXeHBUcDBlQUN1c1pRcUU4YWVvQ1lXYkVqVnpZT3l1UjhuZExPaXY5RlF3TQ?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals CNBC","CNBC",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"Zealand's stock slides as Boehringer-partnered obesity drug underwhelms again in phase 3 - Fierce Biotech","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxOX0pzSDRDNEF0aS1wTEs0T1RnX01XUGRJZy1VNzR0VDlSQUwxMW5oNEpSZ0V4enNhZzZZX1d1OFhFQ0NvbjBna2dHVXBuVHMyRG14UU50VjBUakZaSk5objNvUG1qQ252Sm5OVHpNVWdaaE92S2M1MkctLUd3b3hvQVJKV0VNM1JJeGNqMUlHemJNVDl0SldvWE02WGJqTHJhWElfXzJjRVJycVBCQlpTYTluTGItUzlPbU9F?oc=5","Thu, 01 Oct 2026 10:15:11 GMT","Zealand's stock slides as Boehringer-partnered obesity drug underwhelms again in phase 3 Fierce Biotech","Fierce Biotech",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"Iovance Stock Surges as Strong Melanoma Drug Demand Drives Growth - Barron's","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijgFBVV95cUxQVUUyNW9VOWg0T0hOX0JOcG0zR2Q5TXRaek5UZXNCZHNlc1BEeGZ5T1d4R1dIMVdrQTVzcG8tTHZpSzB2TEY2ZFFQRE5OczVGMWU2V29pbXIyTjdjZ29ybVB2aG12RC13cUxxYnozMW5KSS1wTEJ1WlM0SFl5cW9RTjI2TWo0SXh2cE80WTdn?oc=5","Tue, 29 Sep 2026 16:06:00 GMT","Iovance Stock Surges as Strong Melanoma Drug Demand Drives Growth Barron's","Barron's",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Kodiak Sciences Up 150% At Opening Bell After Drugs Pass Key Trial - Forbes","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxPWkRCRmUxRW5SNnlEcDZBVUhKeGUyQkMtdS1CYmt2bWVEOU1WZ1l3NEhJVXoyc2YyQUUtMWVJNzhIejRqTWNCeU1ldVBUQVhIS05aV1R2UlNvN0hSYlJMbDMwaUF0MEdGV2E0UHAtSDZMeW9aV0ViQUNNNkplQjRqVnozd3VBUklkT3lCaXpMeFpkZWxQY2lZdEt0LUlVVUs0SnpTbDZHc2tMN1NFa2U5ZUdsc1FzYXFyVzFJN09PMA?oc=5","Mon, 28 Sep 2026 13:50:46 GMT","Kodiak Sciences Up 150% At Opening Bell After Drugs Pass Key Trial Forbes","Forbes",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxQMmVLZ3lxQkJGQ0JoUkVVQ3c4OERHS0pYakJjYUxxUTFwOVM5VURsY3RGTExiM3d5bWRZT05yR0JUNWk4WVhlZnJQS1NldURUbnM4c0NCd19HbEFwazdnT3hFZUJRRFM3TVp1T0MwazBMWElRcTl5Nl9GbUNkUWtadlp3cDhUWGF6S2hwc2U2NC1Gdw?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? Yahoo Finance","Yahoo Finance",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"Viking Therapeutics Skyrockets On Obesity Drug Data. Lilly Rises, But Novo Falls. - Investor's Business Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxOeDc4dEJJT1FxTy0yamdRX2plUGkydFZxYWpBQXVQMFZDWElzTUMyUktBUkwtQzcxdDNpMndXNW9lbVVGeEFRMmxmaU11Z3lORWo0SHBUUHRMMUVCR3VXcFd2Z050d2otRHpnemQzN09RNFJ4UGJWUWlQZm5LT2dVLXBFYUdCM19fWHoxdXZuZkVlcWV0emJLQzcxbHhsT050Q2ktSG8yQ3IxV1pzRm5aUmZIbEYyZ3J3blFtbGNHeEg?oc=5","Tue, 22 Sep 2026 07:00:00 GMT","Viking Therapeutics Skyrockets On Obesity Drug Data. Lilly Rises, But Novo Falls. Investor's Business Daily","Investor's Business Daily",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? - The Motley Fool","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimAFBVV95cUxOd1ZkTWhXN0VwSDB5Z2Y0Wm45S21CVjE2dVpBekkza0Y3V0k0dk5CeEdEdlJjdE42X2VIMzFwTXNYM3JKZEpTbzRqYXVaQlRXWUZyMS1jX3VxWFd6Z0R1S1E4LVk4T3V6eUlrU0RCcTRRajdMbXVuRnFIRjZKcnBxVXNURTNsVENqX1JNN3FCeWpmVzF1ZXJFZA?oc=5","Thu, 01 Oct 2026 17:30:00 GMT","Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? The Motley Fool","The Motley Fool",{"title":224,"link":225,"pubDate":226,"description":227,"source":228},"Best Pharmaceutical Stocks to Buy for October 2026 - Zacks Investment Research","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiekFVX3lxTE9GcW9XVjRWa1l3aHFDUEpULXVEX0dabzh3T09fZW8tcWFvUGZzbW80aDBsbFZQWG1NdkRodktNN0F1dGRGUEZzVzN3aEpPYlE4a0VBbXdkNjcxUVFxRHJEZEs2SUNWTUloSS0wTnJ2MldlejNZY0ExU3F3?oc=5","Fri, 02 Oct 2026 07:00:00 GMT","Best Pharmaceutical Stocks to Buy for October 2026 Zacks Investment Research","Zacks Investment Research",{"title":230,"link":231,"pubDate":184,"description":232,"source":233},"Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy - marketwatch.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxQTFl3S0ZXdzJmQ0xKYWlSU2FsaGY0cmQ2VVVFLU1VMjF1bHNMeDd1eDhqWDdXdUtRRm5leVFrUTFQZ2s3QzYwbzBIRVVlRU5IQ1k4MGZfdlZ6dTFyZ1N3T2NNdjcwUkh0UkVlMVJackxHWDgxQWNLLW9DUW1SbnloUU81djBFTnozWVoyYllWRzFWMkFmTTZLZTZacEhqNXJGeXItRlNkRFFGUQ?oc=5","Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy marketwatch.com","marketwatch.com",{"title":235,"link":236,"pubDate":237,"description":238,"source":198},"UniQure Insists Huntington’s Drug Is Still on Track as Stock Plunges 36% - Barron's","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiiwFBVV95cUxPeUEyYTJWSnpYa3ZBWnRjalkwX0h4dlVpRnFhNHhNZUljUjkwbm5TMDI4a0wtYjdCcmFxeXhMS05VaWRLZXJPaW9NUl82QVpkRUVoRVFjbkpLbHQyT1lzUENUaVNHcnlHMnhTWXFfQkpwWWx0TzJfWWRjM3l6V0F0TW4tU3pJQk5tbzNV?oc=5","Tue, 29 Sep 2026 14:16:00 GMT","UniQure Insists Huntington’s Drug Is Still on Track as Stock Plunges 36% Barron's",{"title":240,"link":241,"pubDate":242,"description":243,"source":186},"Pharma stock soars 150% on injectables deal with Wegovy maker Novo - CNBC","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiekFVX3lxTE50dEhodVpIRzhNeE12LW9kMjZCSk1CbFYzd2xMMTRVbktyNmxRWlFCN3lOX252SGZkWWozVnFFQVNrUWdrczY3MWVRWkF3WmJzQXdCTHhCY0x6c3NnMGZtVGdvMGlEWWd1ZUowYndzZ1VkVDA3VnhpT1Z30gF_QVVfeXFMTlBXek1jM3dqLThQMUV2cTU2X1IyTXNqbllndlIwaDJ4X0pJa3Zwbjk1WUk3YW5BY2xMcTdna1UwYnpOdGw3QnNaWUEtcDZBZnk1SHJrdUI1TktScU9yd3Z6R3JWX1lGV3dvOFZwbEI5cGFkVEtOQWwyeTVnSlAydw?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","Pharma stock soars 150% on injectables deal with Wegovy maker Novo CNBC",{"title":245,"link":246,"pubDate":247,"description":248,"source":216},"Uniqure Dives 37% On Another Shock For Its Gene Therapy - Investor's Business Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinAFBVV95cUxPVG5CQUg5RjFDS0xXdVlZMGRyYnpadlBIRFV3aURWTDZNQUdQMWlsa1F4dHRhTTNDWldSVHFNSDYycEZ0LXZaa2xoVEhRS3hFdlpXaFFrbzRSY1lxclhDSGl1SGVhMFpfeFd1enZRMDYxSGpEdEVBYW1yQ2xJR3dxelhmeFk2X1BVSTlIcWVjMUU4YURiT3JxLTV0QkQ?oc=5","Tue, 29 Sep 2026 20:56:00 GMT","Uniqure Dives 37% On Another Shock For Its Gene Therapy Investor's Business Daily",{"title":250,"link":251,"pubDate":252,"description":253,"source":222},"Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It's Not Too Late to Buy the Stock. - The Motley Fool","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilwFBVV95cUxQck1vNmZhVDRQS1gwejdFbnJXMTNHR0lUNFVvTl9ZeENTY0xQS2NoYy1ta0xFM2YtNVROTUFsNDRyMFcwY0dXM0c4cXZiczM1d0drekF4dVJWLVJzb0lUOFZSS3daamlIa2tHVGJmcDg0Y1lBYVA5a3UtVHhoUWx1THFnWVNLd1FjS280SGQ5VVRGd09USWln?oc=5","Wed, 30 Sep 2026 22:00:00 GMT","Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It's Not Too Late to Buy the Stock. The Motley Fool",{"title":255,"link":256,"pubDate":257,"description":258,"source":210},"MRNA Stock Eyes Best Year Ever: Analyst Calls China’s AI Drug Lead ‘Baseless’ As Moderna Awaits Cancer Data - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijwFBVV95cUxNVzU5NjNmNlBNNjZ4OVVZMEJIVk1tUm55eDNiX1V6WVVXbDAxRVZTdS1BN2hnOXhkdnZ0NGVJbFhxNWROR3VyQ1lmMkRYcV9DQ090aHBteGszeUZ4T254N3JGSWRnZEpWazRRbzBvZXlwRzRPeXZVdGVDTFZaOFoxVDFZQUZGeTctSldEdEo3cw?oc=5","Mon, 28 Sep 2026 07:59:02 GMT","MRNA Stock Eyes Best Year Ever: Analyst Calls China’s AI Drug Lead ‘Baseless’ As Moderna Awaits Cancer Data Yahoo Finance",{"title":260,"link":261,"pubDate":184,"description":262,"source":186},"Novo shares slide as drugmaker lays out post-Wegovy growth strategy - CNBC","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiigFBVV95cUxNZFAtUVFDOHFJMHFvZHBWSll4SFJZM1VTQWhWX2g0VkVPSTVUclpDVlpCX2gzRVY3SEFTV3liTTgzU1BNcm9aX01TVHlsdjNKbS1UbGhtU3lhXzFpTjNLR1pvZGk3cUZkLVI2Wk9qaS1mOTZPYVhDaXBacjJrZS0zamZSdEpVcWtRWWfSAY8BQVVfeXFMTzZOWXBXMzNpbjZJa1RhLXg5MnNhYS03dnVHTllSekFJWXppa09zbkpOVF9QX1k3SHdhejNPYjRZbnhybGpjNmdEbW43RGtiUVdUTTdrbmJNTE5BaGN6cmtEczNOQnM5UEtRMW42dFVmMEw1SnI3aEhHeDJ5MU9yS1N1dXpUeTlWekE0RTFwOTA?oc=5","Novo shares slide as drugmaker lays out post-Wegovy growth strategy CNBC",{"title":264,"link":265,"pubDate":266,"description":267,"source":198},"Kodiak Stock Gains 183% as New Eye Drugs Take Aim at Regeneron’s Eylea - Barron's","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiiAFBVV95cUxPMkxGVjVidDVxdHRPZk9LcDEzTHViNFNLblBuUHVrSXQyakd0cjhveXVQVUVTNU5JNkMyclVWNXo1VmtwOXg2SE04azhVdmRlN1hZR2psZ3lWa3dVY3J1V0FzV25JcDdVak9kOUxTbi0wUlVJeDdPZ2o5dWI5WDNGU252MnVCTmNo?oc=5","Sun, 04 Oct 2026 13:01:29 GMT","Kodiak Stock Gains 183% as New Eye Drugs Take Aim at Regeneron’s Eylea Barron's",{"title":269,"link":270,"pubDate":208,"description":271,"source":210},"Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxQc09CbFY3bndtZ2tqaE00d3c0TDA1R1lBNHNlbXVvMFRMeVVRTllBcWs0VXlSQVBxdWgyMkd3RlF0Y2RGcjdKdnQ2YV9WeGtpcGYwOFM2SURnbUpRS09RWkJIdC1xQU9wOF9VNGJ3RjE0TURjdEJXMFd6ZGdxTGRMNzFBbDA4U0N1V1kzcndfd2g3YWZNci11N1BqTQ?oc=5","Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall? Yahoo Finance",{"title":273,"link":274,"pubDate":178,"description":275,"source":198},"Immunovant Stock Slides After Biotech Scraps Autoimmune Drug Program - Barron's","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiigFBVV95cUxNaFl6RzBELTAwaDRBNi1Dd1hqUWpTSU9wRDhTTmFvTTByVFRNWTlBRmNXVURoS0FJQWZ0d2Y2NFhUSXlSQ0xSaDhINXNKM2U4MWdidEttYlJOeUIxVVdoSUlhd0loMi1JUk1kSVIyb0l4WkdfeFUzQ2I1VUtJMTBnYkd2cUE4Z0ZwYUE?oc=5","Immunovant Stock Slides After Biotech Scraps Autoimmune Drug Program Barron's",{"title":277,"link":278,"pubDate":279,"description":280,"source":198},"Cigna Stock: Specialty Drug Growth Takes Focus at Investor Day - Barron's","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiigFBVV95cUxQYndya2JiSWRhMmd1b01WVElHWkVBRW82Tlh4eXoxREx1REdaeEsyeUJXcWZSUkZrYmdlY1hRc0lkWlJHS3dZYWNfeElCenVnajVhQUo4UWx6aGlTLWlMbGFjM2hxeFZZUTl0WF9DamxyazU3VGc0dnhNR3ZKaXdVeklqeDU2Y2c4eGc?oc=5","Wed, 30 Sep 2026 15:43:00 GMT","Cigna Stock: Specialty Drug Growth Takes Focus at Investor Day Barron's"]